Jesper Zeuthen

2022 – 2024

Board of Directors, INPROTHER ApS

2011 – 2021

Chief Executive Officer, GENOMIC EXPRESSION ApS

2009 – 2010

Chairman, Renovaro Biosciences Denmark ApS

2008 – 2009

Chairman, UDVIKLINGSSELSKABET LP AF 11. JANUAR 2001 A/S

2007 – 2007

Chairman, ZEALAND PHARMA A/S

2006 – 2009

Board of Directors, TOPOTARGET A/S

2006 – 2008

Chairman, BOREAN PHARMA ApS

2005 – 2008

Deputy, AGC Biologics A/S

2005 – 2006

Board of Directors, PROTEOPHARMA ApS

2004 – 2009

Stakeholder, K/S SUNSTONE BIOMEDICAL VENTURE ANNEX I

2004 – 2009

Stakeholder, K/S SUNSTONE BIOMEDICAL VENTURE ANNEX III

2004 – 2009

Stakeholder, K/S SUNSTONE BIOMEDICAL VENTURE ANNEX II

2004 – 2009

Management, A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR

2004 – 2009

Management, K/S BI BIOMEDICAL VENTURE IV

2004 – 2006

Chairman, ROCHE BIO DENMARK A/S

2004 – 2004

Chairman, ZYMENEX HOLDING ApS

2002 – 2006

Chairman, RICC A/S

2001 – 2011

Management, KUROS HOLDING ApS

2001 – 2009

Management, A/S BI BIOMEDICINSK VENTURE III KOMPLEMENTAR

2001 – 2009

Management, P/S SUNSTONE BIOMEDICINSK VENTURE III

2001 – 2004

Board of Directors, BIOVISION A/S

2000 – 2009

Management, AKTIESELSKABET BI BIOMEDICINSK VENTURE II

2000 – 2009

Management, BANKINVEST PRIVATE EQUITY A/S

1999 – 2003

Chairman, GENMAB A/S